Cite
HARVARD Citation
Birbara, C. et al. (2013). OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial. Annals of the rheumatic diseases. pp. A85-A86. [Online].